• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部疾病中肿瘤相关巨噬细胞(TAM)机制的最新进展。

Recent advances in TAM mechanisms in lung diseases.

作者信息

Ban Jiaqi, Qian Jiayi, Zhang Chi, Li Jun

机构信息

School of Public Health, The key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, No.6 Ankang Road, Guian New Area, Guiyang, 561113, Guizhou, China.

School of Clinical Medicine, Ministry of Education, Guizhou Medical University, Guiyang, Guizhou, 561113, People's Republic of China.

出版信息

J Transl Med. 2025 Apr 26;23(1):479. doi: 10.1186/s12967-025-06398-2.

DOI:10.1186/s12967-025-06398-2
PMID:40287707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12032715/
Abstract

TYRO3, MERTK, and AXL receptor tyrosine kinases, collectively known as TAM receptors, play a vital role in maintaining lung tissue homeostasis by regulating integrity and self-renewal. These receptors activate signalling pathways that inhibit apoptosis, promote cell proliferation and differentiation, mediate cell adhesion and migration, and perform other essential biological functions. Additionally, TAM receptors are implicated in mechanisms that suppress anti-tumor immunity and confer resistance to immune checkpoint inhibitors. Disruption of the homeostatic balances can lead to pathological conditions such as lung inflammation, fibrosis, or tumors. Recent studies highlight their significant role in COVID-19-induced lung injury. However, the exact mechanisms by which TAM receptors contribute to lung diseases remain unclear. This article reviews the potential mechanisms of TAM receptor involvement in disease progression, focusing on lung inflammation, fibrosis, cancer, and COVID-19-induced lung injury. It also explores future research aspects and the therapeutic potentials of targeting TAM receptors, providing a theoretical foundation for understanding lung disease mechanisms and identifying treatment targets.

摘要

TYRO3、MERTK和AXL受体酪氨酸激酶统称为TAM受体,它们通过调节肺组织的完整性和自我更新,在维持肺组织稳态中发挥着至关重要的作用。这些受体激活的信号通路可抑制细胞凋亡、促进细胞增殖和分化、介导细胞黏附和迁移,并执行其他重要的生物学功能。此外,TAM受体还参与抑制抗肿瘤免疫和赋予对免疫检查点抑制剂耐药性的机制。体内平衡的破坏会导致诸如肺部炎症、纤维化或肿瘤等病理状况。最近的研究突显了它们在新冠病毒诱导的肺损伤中所起的重要作用。然而,TAM受体导致肺部疾病的确切机制仍不清楚。本文综述了TAM受体参与疾病进展的潜在机制,重点关注肺部炎症、纤维化、癌症以及新冠病毒诱导的肺损伤。文章还探讨了未来的研究方向以及靶向TAM受体的治疗潜力,为理解肺部疾病机制和确定治疗靶点提供理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/f9a7060b2d81/12967_2025_6398_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/c64735d4b31d/12967_2025_6398_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/020221786655/12967_2025_6398_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/f9a7060b2d81/12967_2025_6398_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/c64735d4b31d/12967_2025_6398_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/020221786655/12967_2025_6398_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c1/12032715/f9a7060b2d81/12967_2025_6398_Fig3_HTML.jpg

相似文献

1
Recent advances in TAM mechanisms in lung diseases.肺部疾病中肿瘤相关巨噬细胞(TAM)机制的最新进展。
J Transl Med. 2025 Apr 26;23(1):479. doi: 10.1186/s12967-025-06398-2.
2
Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.酪氨酸激酶受体 Tyro3、Axl 和 Mer 受体激酶(Mertk)受体在血小板激活和血栓形成中发挥不同的作用。
Cell Commun Signal. 2018 Dec 12;16(1):98. doi: 10.1186/s12964-018-0308-0.
3
Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.靶向蛋白降解剂靶向降解 MERTK 和其他 TAM 受体同源物。
Front Immunol. 2023 Jul 20;14:1135373. doi: 10.3389/fimmu.2023.1135373. eCollection 2023.
4
TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.TAM 受体途径在神经炎症和神经变性的十字路口。
Dis Markers. 2019 Sep 15;2019:2387614. doi: 10.1155/2019/2387614. eCollection 2019.
5
TAM receptors in cardiovascular disease.TAM 受体与心血管疾病。
Cardiovasc Res. 2019 Jul 1;115(8):1286-1295. doi: 10.1093/cvr/cvz100.
6
TAM receptors and their ligand-mediated activation: Role in atherosclerosis.TAM 受体及其配体介导的激活:在动脉粥样硬化中的作用。
Int Rev Cell Mol Biol. 2020;357:21-33. doi: 10.1016/bs.ircmb.2020.09.001. Epub 2020 Oct 5.
7
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.Axl 和 Mertk 受体通过联合致癌信号和逃避宿主抗肿瘤免疫来共同促进乳腺癌的进展。
Cancer Res. 2021 Feb 1;81(3):698-712. doi: 10.1158/0008-5472.CAN-20-2066. Epub 2020 Nov 25.
8
Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.受体酪氨酸激酶 Tyro3、Axl 和 Mertk 对抗体诱导的关节炎有不同的作用。
Cell Commun Signal. 2023 Aug 3;21(1):195. doi: 10.1186/s12964-023-01133-0.
9
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.靶向 TAM 受体(TYRO3、AXL 和 MERTK):肿瘤微环境中巨噬细胞的作用。
Mol Cancer. 2019 May 14;18(1):94. doi: 10.1186/s12943-019-1022-2.
10
TAM receptors in phagocytosis: Beyond the mere internalization of particles.吞噬作用中的 TAM 受体:超越颗粒的单纯内化。
Immunol Rev. 2023 Oct;319(1):7-26. doi: 10.1111/imr.13267. Epub 2023 Aug 19.

本文引用的文献

1
Orderly Regulation of Macrophages and Fibroblasts by Axl in Bleomycin-Induced Pulmonary Fibrosis in Mice.Axl对博来霉素诱导的小鼠肺纤维化中巨噬细胞和成纤维细胞的有序调控
J Cell Mol Med. 2025 Jan;29(1):e70321. doi: 10.1111/jcmm.70321.
2
PFKP silencing suppresses tumor growth via the AXL-MET axis.磷酸果糖激酶-1(PFKP)沉默通过AXL-间质上皮转化因子(MET)轴抑制肿瘤生长。
Int J Biol Sci. 2024 Nov 11;20(15):6056-6072. doi: 10.7150/ijbs.100525. eCollection 2024.
3
Research progress on the role of bypass activation mechanisms in resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
旁路激活机制在非小细胞肺癌对酪氨酸激酶抑制剂耐药中的作用研究进展
Front Oncol. 2024 Nov 8;14:1447678. doi: 10.3389/fonc.2024.1447678. eCollection 2024.
4
CD73 promotes non-small cell lung cancer metastasis by regulating Axl signaling independent of GAS6.CD73 通过调控非 GAS6 依赖的 Axl 信号促进非小细胞肺癌转移。
Proc Natl Acad Sci U S A. 2024 Oct 22;121(43):e2404709121. doi: 10.1073/pnas.2404709121. Epub 2024 Oct 18.
5
Dexmedetomidine attenuates sepsis-associated acute lung injury by regulating macrophage efferocytosis through the ROS/ADAM10/AXL pathway.右美托咪定通过 ROS/ADAM10/AXL 通路调节巨噬细胞胞噬作用来减轻脓毒症相关性急性肺损伤。
Int Immunopharmacol. 2024 Dec 5;142(Pt A):112832. doi: 10.1016/j.intimp.2024.112832. Epub 2024 Oct 2.
6
Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer.针对 EGFR 驱动突变体的定制设计反义寡核苷酸用于非小细胞肺癌的个体化治疗。
EBioMedicine. 2024 Oct;108:105356. doi: 10.1016/j.ebiom.2024.105356. Epub 2024 Sep 19.
7
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy.AXL 表达反映了影响免疫检查点抑制剂单药治疗的非小细胞肺癌患者结局的肿瘤免疫细胞动态。
Front Immunol. 2024 Aug 21;15:1444007. doi: 10.3389/fimmu.2024.1444007. eCollection 2024.
8
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib.一种靶向 EGFR 和 AXL 的双特异性抗体可延缓奥希替尼耐药。
Cell Rep Med. 2024 Sep 17;5(9):101703. doi: 10.1016/j.xcrm.2024.101703. Epub 2024 Aug 30.
9
Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancer.奥希替尼、AXL 抑制剂和 FGFR 抑制剂三联疗法可提高 EGFR 突变型非小细胞肺癌的疗效。
Cancer Lett. 2024 Aug 28;598:217124. doi: 10.1016/j.canlet.2024.217124. Epub 2024 Jul 24.
10
Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells.初始 AXL 和 MCL-1 抑制有助于消除 EGFR 突变型肺癌细胞对 lazertinib 的耐受。
Cancer Sci. 2024 Oct;115(10):3333-3345. doi: 10.1111/cas.16292. Epub 2024 Jul 22.